Vanguard Global Advisers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$71.7M Sell
830,483
-2,596
-0.3% -$216K 0.03% 338
2026
Q2
$56.1M Sell
833,079
-9,559
-1% -$637K 0.03% 385
2026
Q1
$52.9M Buy
+842,638
New +$58.7M 0.03% 388

Other funds holding DXCM

Vanguard Global Advisers's DXCM Position: Q3 2026 in Review

Vanguard Global Advisers reduced its DexCom (DXCM) stake by 0.31% in Q3 2026, selling an estimated $216K and leaving 830,483 shares worth $71.7M. The position accounts for 0.03% of the portfolio, ranked #338.

Vanguard Global Advisers first reported a position in DXCM in Q1 2026 and has held it in 3 quarters since. 953 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Vanguard Global Advisers held 830,483 shares of DexCom worth $71.7M as of Q3 2026.
  • Vanguard Global Advisers sold 2,596 DexCom shares in Q3 2026, an estimated $216K.
  • DexCom made up 0.03% of Vanguard Global Advisers's portfolio in Q3 2026, its #338 holding.
  • Vanguard Global Advisers first reported a position in DexCom in Q1 2026 and has held it in 3 quarters since.
  • 953 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.